| SYK |
Report |
Revenue |
BEAT |
pred ~$6.640B vs. cons $6.571B |
MEDIUM |
| SYK |
Report |
Organic sales growth |
BEAT |
pred ~9.70% vs. cons 9.30% |
MEDIUM |
| SYK |
Report |
Adjusted EPS |
BEAT |
pred ~$3.520 vs. cons $3.475 |
MEDIUM |
| SYK |
Guide |
Organic sales growth (FY26) |
UNCHANGED |
guide ~8%-9.5% vs. cons 8.81% |
MEDIUM |
| SYK |
Guide |
Adjusted EPS (FY26) |
UNCHANGED |
guide ~$14.90-$15.10 vs. cons $14.98 |
MEDIUM |
| SYK |
Guide |
Capital recovery cadence (2H26) |
UNCHANGED |
guide ~back-half weighted vs. cons UNVERIFIED |
LOW |
| SYK |
Return |
Day-1 residual (stock − beta × S&P 500) |
-3.0% |
— |
LOW |
| SYK |
Return |
5-day cumulative residual |
-4.5% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — FY maintenance confirms rather than improves out-period economics |
LOW |